TOWA PHARMACEUTICAL CO., LTD. produces generic drugs mainly for elderly.  The Company also wholesales medicine and medical products of other pharmaceuticals.

Consolidated Financial Results For The Six Months Ended September 30, 2025 (Based On Japanese Gaap)

Supplementary Material For The Financial Results For The Second Quarter (Interim Period) Of The Year Ending March 31, 2026

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Towa Pharmaceutical (4553 JP)

Consolidated Financial Results For The Six Months Ended September 30, 2025 (Based On Japanese Gaap)

Supplementary Material For The Financial Results For The Second Quarter (Interim Period) Of The Year Ending March 31, 2026

Consolidated Financial Results For The Three Months Ended June 30, 2025 (Based On Japanese Gaap)

Supplementary Material For The Financial Results For The First Quarter Of The Year Ending March 31, 2026

Notice Of A Fire At Part Of The First Solid Dosage Building At Our Yamagata Plant (Third Report)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)